Metastatic Malignant Melanoma and Renal Cell Carcinoma
1 clinical trials · Condition
◉ Watch Metastatic Malignant Melanoma and Renal Cell Carcinoma
| Record | Firm | Date |
|---|---|---|
| Irradiated Donor Lymphocyte Infusion Plus High-dose IL-2 (NCT01925118) | Seoul National University Hospital | 2013-08-01 |
Track Metastatic Malignant Melanoma and Renal Cell Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.